What is the market capitalization of NEUROTHERA LABS INC?

NEUROTHERA LABS INC (NTLX.V) has a market capitalization of approximately 15,282,000 CAD.

Where can I buy NTLX.V in Canada?

NTLX.V can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

NTLX.V

NEUROTHERA LABS INC

NEUROTHERA LABS INC (NTLX.V) is an American company in the healthcare sector, listed on TSXV. Market capitalization of 15 million CAD (micro-cap).

Details

Price0.18 CAD

Market cap15.28 M CAD

Payout ratio0.00%

ROE-399.18%

Debt / Equity144.14%

SectorHealthcare

Websiteneurothera.com

Updated 2h ago

Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware. Neurothera Labs Inc. is a subsidiary of SciSparc Ltd.